Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock

Michael H Picard1, Ravin Davidoff, Lynn A Sleeper

  • 1Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA. MHPicard@partners.org

Circulation
|January 23, 2003
PubMed

Insights

Echocardiography reveals that left ventricular ejection fraction (LVEF) and mitral regurgitation (MR) severity predict survival in cardiogenic shock. Early revascularization (ERV) benefits patients regardless of their initial LVEF or MR.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Critical Care Medicine

Background:

  • Echocardiography is crucial for diagnosing and managing myocardial infarction.
  • Prognostic value of early cardiac structural/functional features in cardiogenic shock remains unclear.
  • The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK (SHOCK) trial investigated early revascularization (ERV) versus initial medical stabilization (IMS).

Purpose of the Study:

  • Describe echocardiographic features in cardiogenic shock.
  • Identify early echocardiographic findings predicting outcomes.
  • Examine feature-treatment interactions and insights into ERV survival benefit.

Main Methods:

  • Quantitative assessment of 175 echocardiograms within 24 hours of randomization.
  • Analysis of 169 suitable echocardiograms from the SHOCK trial.
  • Multivariate analysis to identify independent predictors of survival.

Main Results:

  • Mean left ventricular ejection fraction (LVEF) was 31%; 39.1% had moderate or greater mitral regurgitation (MR).
  • Independent predictors of survival were MR severity and LVEF.
  • ERV strategy showed survival benefit across all LVEF and MR levels.

Conclusions:

  • Acute cardiogenic shock presents with diverse cardiac abnormalities.
  • Initial LVEF and MR severity predict short- and long-term mortality.
  • ERV provides benefits irrespective of baseline LVEF or MR severity.
Abstract